Ekso Bionics (NASDAQ:EKSO) Price Target Cut to $1.00 by Analysts at Lake Street Capital

Ekso Bionics (NASDAQ:EKSO) had its price target cut by investment analysts at Lake Street Capital from $2.00 to $1.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Lake Street Capital’s price objective would indicate a potential upside of 110.00% from the stock’s current price.

EKSO has been the subject of several other research reports. StockNews.com assumed coverage on shares of Ekso Bionics in a research report on Monday. They set a “hold” rating for the company. HC Wainwright reiterated a “buy” rating and issued a $9.00 target price on shares of Ekso Bionics in a report on Tuesday.

Ekso Bionics Trading Down 1.2 %

Shares of NASDAQ EKSO traded down $0.01 during midday trading on Tuesday, reaching $0.48. The stock had a trading volume of 451,837 shares, compared to its average volume of 350,367. The company’s 50 day moving average price is $0.61 and its 200 day moving average price is $0.82. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.14 and a current ratio of 2.81. Ekso Bionics has a twelve month low of $0.40 and a twelve month high of $2.16. The firm has a market cap of $10.48 million, a price-to-earnings ratio of -0.73 and a beta of 1.46.

Ekso Bionics (NASDAQ:EKSO) last released its earnings results on Monday, March 3rd. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by ($0.07). Ekso Bionics had a negative net margin of 62.95% and a negative return on equity of 83.09%. The firm had revenue of $5.09 million during the quarter, compared to analyst estimates of $5.05 million. As a group, sell-side analysts expect that Ekso Bionics will post -0.48 EPS for the current year.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.